PLATO and immunotherapy trials in anal cancer

David Sebag-Montefiore, MRCP, FRCR, Leeds Teaching Hospitals NHS Trust, Leeds, UK, talks about two different trials with strategies for improving outcomes from anal cancer treatment; amending dosage of radiotherapy (PLATO; ISRCTN88455282) and novel agent combinations (CORINTH; NCT04046133). This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

• فئة